Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 100

1.

In the Hospital: Laura Shea.

Ludwin S, Narayana S.

J Hosp Med. 2019 Feb 20;14:E1-E2. doi: 10.12788/jhm.3113. [Epub ahead of print] No abstract available.

PMID:
30794137
2.

Training Residents in Hospital Medicine: The Hospitalist Elective National Survey.

Ludwin S, Harrison JD, Ranji S, Sharpe BA, Kneeland P.

J Hosp Med. 2018 Sep 1;13(9):623-625. doi: 10.12788/jhm.2952. Epub 2018 Mar 26.

PMID:
29578550
3.

Immunology of oligodendrocyte precursor cells in vivo and in vitro.

Antel JP, Lin YH, Cui QL, Pernin F, Kennedy TE, Ludwin SK, Healy LM.

J Neuroimmunol. 2019 Jun 15;331:28-35. doi: 10.1016/j.jneuroim.2018.03.006. Epub 2018 Mar 13.

PMID:
29566973
4.

Denah Joseph: "In the Hospital".

Ludwin SM, Narayana S.

J Hosp Med. 2018 Mar;13(3):203-204. doi: 10.12788/jhm.2951. No abstract available.

PMID:
29505623
5.

In the Hospital: Series Introduction.

Ludwin SM, Narayana S.

J Hosp Med. 2018 Mar;13(3):202. doi: 10.12788/jhm.2950. No abstract available.

PMID:
29505622
6.

Dilemmas in medical ethics in the age of big data.

Ludwin SK, Murray TJ.

Mult Scler. 2017 Sep;23(10):1306-1308. doi: 10.1177/1352458517722056. Epub 2017 Jul 26. No abstract available.

PMID:
28743225
7.

Sublethal oligodendrocyte injury: A reversible condition in multiple sclerosis?

Cui QL, Khan D, Rone M, T S Rao V, Johnson RM, Lin YH, Bilodeau PA, Hall JA, Rodriguez M, Kennedy TE, Ludwin SK, Antel JP.

Ann Neurol. 2017 Jun;81(6):811-824. doi: 10.1002/ana.24944. Epub 2017 Jun 2.

PMID:
28470695
8.

An updated histological classification system for multiple sclerosis lesions.

Kuhlmann T, Ludwin S, Prat A, Antel J, Brück W, Lassmann H.

Acta Neuropathol. 2017 Jan;133(1):13-24. doi: 10.1007/s00401-016-1653-y. Epub 2016 Dec 17.

PMID:
27988845
9.

Astrocytes in multiple sclerosis.

Ludwin SK, Rao VTs, Moore CS, Antel JP.

Mult Scler. 2016 Aug;22(9):1114-24. doi: 10.1177/1352458516643396. Epub 2016 Apr 19. Review.

PMID:
27207458
10.

Oligodendrogliopathy in Multiple Sclerosis: Low Glycolytic Metabolic Rate Promotes Oligodendrocyte Survival.

Rone MB, Cui QL, Fang J, Wang LC, Zhang J, Khan D, Bedard M, Almazan G, Ludwin SK, Jones R, Kennedy TE, Antel JP.

J Neurosci. 2016 Apr 27;36(17):4698-707. doi: 10.1523/JNEUROSCI.4077-15.2016.

11.

MerTK Is a Functional Regulator of Myelin Phagocytosis by Human Myeloid Cells.

Healy LM, Perron G, Won SY, Michell-Robinson MA, Rezk A, Ludwin SK, Moore CS, Hall JA, Bar-Or A, Antel JP.

J Immunol. 2016 Apr 15;196(8):3375-84. doi: 10.4049/jimmunol.1502562. Epub 2016 Mar 9.

12.

Margaret Grace Norman, MD, FRCP(C) October 19, 1933-May 17, 2015.

Ludwin SK.

J Neuropathol Exp Neurol. 2015 Dec;74(12):1183-4. No abstract available.

PMID:
26904768
13.

MicroRNA Expression Patterns in Human Astrocytes in Relation to Anatomical Location and Age.

Rao VT, Ludwin SK, Fuh SC, Sawaya R, Moore CS, Ho MK, Bedell BJ, Sarnat HB, Bar-Or A, Antel JP.

J Neuropathol Exp Neurol. 2016 Feb;75(2):156-66.

PMID:
26802178
14.

Integration of Th17- and Lymphotoxin-Derived Signals Initiates Meningeal-Resident Stromal Cell Remodeling to Propagate Neuroinflammation.

Pikor NB, Astarita JL, Summers-Deluca L, Galicia G, Qu J, Ward LA, Armstrong S, Dominguez CX, Malhotra D, Heiden B, Kay R, Castanov V, Touil H, Boon L, O'Connor P, Bar-Or A, Prat A, Ramaglia V, Ludwin S, Turley SJ, Gommerman JL.

Immunity. 2015 Dec 15;43(6):1160-73. doi: 10.1016/j.immuni.2015.11.010.

15.

Capsule Commentary on Jenssen et al., Using Digital Technology to Engage and Communicate with Patients: A Survey of Patient Attitudes.

Ludwin S, Greysen SR.

J Gen Intern Med. 2016 Jan;31(1):107. doi: 10.1007/s11606-015-3530-0. No abstract available.

16.

Sequencing the immunopathologic heterogeneity in multiple sclerosis.

Antel JP, Ludwin SK, Bar-Or A.

Ann Clin Transl Neurol. 2015 Sep;2(9):873-4. doi: 10.1002/acn3.230. No abstract available.

17.

Use of smartphones and mobile devices in hospitalized patients: Untapped opportunities for inpatient engagement.

Ludwin S, Greysen SR.

J Hosp Med. 2015 Jul;10(7):459-61. doi: 10.1002/jhm.2365. Epub 2015 Apr 15. No abstract available.

18.

P2Y12 expression and function in alternatively activated human microglia.

Moore CS, Ase AR, Kinsara A, Rao VT, Michell-Robinson M, Leong SY, Butovsky O, Ludwin SK, Séguéla P, Bar-Or A, Antel JP.

Neurol Neuroimmunol Neuroinflamm. 2015 Mar 19;2(2):e80. doi: 10.1212/NXI.0000000000000080. eCollection 2015 Apr. Erratum in: Neurol Neuroimmunol Neuroinflamm. 2015 Jun;2(3):e106.

19.

miR-155 as a multiple sclerosis-relevant regulator of myeloid cell polarization.

Moore CS, Rao VT, Durafourt BA, Bedell BJ, Ludwin SK, Bar-Or A, Antel JP.

Ann Neurol. 2013 Nov;74(5):709-20. doi: 10.1002/ana.23967. Epub 2013 Sep 23.

PMID:
23818336
20.

Cytotoxic NKG2C+ CD4 T cells target oligodendrocytes in multiple sclerosis.

Zaguia F, Saikali P, Ludwin S, Newcombe J, Beauseigle D, McCrea E, Duquette P, Prat A, Antel JP, Arbour N.

J Immunol. 2013 Mar 15;190(6):2510-8. doi: 10.4049/jimmunol.1202725. Epub 2013 Feb 8.

21.

Human fetal oligodendrocyte progenitor cells from different gestational stages exhibit substantially different potential to myelinate.

Cui QL, D'Abate L, Fang J, Leong SY, Ludwin S, Kennedy TE, Antel J, Almazan G.

Stem Cells Dev. 2012 Jul 20;21(11):1831-7. doi: 10.1089/scd.2011.0494. Epub 2012 Jan 26.

PMID:
22122665
22.

Increased sedation requirements during endoscopy in patients with celiac disease.

Lebwohl B, Hassid B, Ludwin S, Lewis SK, Tennyson CA, Neugut AI, Green PH.

Dig Dis Sci. 2012 Apr;57(4):994-9. doi: 10.1007/s10620-011-1959-5. Epub 2011 Nov 4.

PMID:
22052448
23.

Epstein-Barr Virus and MS:Causality or Association?

Ludwin S, Jacobson S.

Int MS J. 2011 May;17(2):39-43.

24.

Neurobiological effects of sphingosine 1-phosphate receptor modulation in the cuprizone model.

Kim HJ, Miron VE, Dukala D, Proia RL, Ludwin SK, Traka M, Antel JP, Soliven B.

FASEB J. 2011 May;25(5):1509-18. doi: 10.1096/fj.10-173203. Epub 2011 Jan 19.

25.

Neuropathology training and status in Canada.

Ludwin SK.

Can J Neurol Sci. 2010 Mar;37(2):159. No abstract available.

PMID:
20437924
26.

Fingolimod (FTY720) enhances remyelination following demyelination of organotypic cerebellar slices.

Miron VE, Ludwin SK, Darlington PJ, Jarjour AA, Soliven B, Kennedy TE, Antel JP.

Am J Pathol. 2010 Jun;176(6):2682-94. doi: 10.2353/ajpath.2010.091234. Epub 2010 Apr 22.

27.

Neurological picture. Hereditary diffuse leukoencephalopathy with neuroaxonal spheroids: novel imaging findings.

Boissé L, Islam O, Woulfe J, Ludwin SK, Brunet DG.

J Neurol Neurosurg Psychiatry. 2010 Mar;81(3):313-4. doi: 10.1136/jnnp.2009.180224. No abstract available.

PMID:
20185471
28.

Statin therapy inhibits remyelination in the central nervous system.

Miron VE, Zehntner SP, Kuhlmann T, Ludwin SK, Owens T, Kennedy TE, Bedell BJ, Antel JP.

Am J Pathol. 2009 May;174(5):1880-90. doi: 10.2353/ajpath.2009.080947. Epub 2009 Apr 6.

29.

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.

Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, Hau P, Brandes AA, Gijtenbeek J, Marosi C, Vecht CJ, Mokhtari K, Wesseling P, Villa S, Eisenhauer E, Gorlia T, Weller M, Lacombe D, Cairncross JG, Mirimanoff RO; European Organisation for Research and Treatment of Cancer Brain Tumour and Radiation Oncology Groups; National Cancer Institute of Canada Clinical Trials Group.

Lancet Oncol. 2009 May;10(5):459-66. doi: 10.1016/S1470-2045(09)70025-7. Epub 2009 Mar 9.

PMID:
19269895
30.

The pathogenesis of multiple sclerosis: relating human pathology to experimental studies.

Ludwin SK.

J Neuropathol Exp Neurol. 2006 Apr;65(4):305-18. Review.

PMID:
16691112
31.

Tissue preconditioning may explain concentric lesions in Baló's type of multiple sclerosis.

Stadelmann C, Ludwin S, Tabira T, Guseo A, Lucchinetti CF, Leel-Ossy L, Ordinario AT, Brück W, Lassmann H.

Brain. 2005 May;128(Pt 5):979-87. Epub 2005 Mar 17.

PMID:
15774507
32.

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.

Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group.

N Engl J Med. 2005 Mar 10;352(10):987-96.

33.

Pathologic classification systems in MS: what is their significance?

Ludwin SK.

Mult Scler. 2005 Feb;11(1):106-7. Review. No abstract available.

PMID:
15732280
34.

Unique clinical and pathological features in HLA-DRB1*0401-restricted MBP 111-129-specific humanized TCR transgenic mice.

Quandt JA, Baig M, Yao K, Kawamura K, Huh J, Ludwin SK, Bian HJ, Bryant M, Quigley L, Nagy ZA, McFarland HF, Muraro PA, Martin R, Ito K.

J Exp Med. 2004 Jul 19;200(2):223-34.

35.

Limited repertoire of HLA-DRB1*0401-restricted MBP111-129-specific T cells in HLA-DRB1*0401 Tg mice and their pathogenic potential.

Huh J, Yao K, Quigley L, Ludwin SK, McFarland HF, Muraro PA, Martin R, Ito K.

J Neuroimmunol. 2004 Jun;151(1-2):94-102.

PMID:
15145608
36.

A phase II study of topotecan in patients with anaplastic oligodendroglioma or anaplastic mixed oligoastrocytoma.

Bélanger K, MacDonald D, Cairncross G, Gertler S, Forsyth P, Burdette-Radoux S, Bergeron J, Soulières D, Ludwin S, Wainman N, Eisenhauer E.

Invest New Drugs. 2003 Nov;21(4):473-80.

PMID:
14586216
37.

Global democratic consensus on neuropathological disease criteria.

Achim C, Auer R, Bergeron C, Cardozo A, Deprez M, de Vos R, Duyckaerts C, Egensperger R, Esiri M, Frosch MP, Giannini C, Goebel HH, Graeber MB, Graham DI, Gray F, Haltia M, Hashizume Y, Ikeda K, Ironside JW, Kreutzberg GW, Lantos P, Lowe J, Ludwin S, Matsumoto Y, Olsson Y, Sasaki A, Scheithauer BW, Takahashi H, Tolnay M, Trojanowski JQ, Troost D, de F Webster H.

Lancet Neurol. 2002 Oct;1(6):340. No abstract available.

38.

High frequency of human herpesvirus 6 DNA in multiple sclerosis plaques isolated by laser microdissection.

Cermelli C, Berti R, Soldan SS, Mayne M, D'ambrosia JM, Ludwin SK, Jacobson S.

J Infect Dis. 2003 May 1;187(9):1377-87. Epub 2003 Apr 9.

PMID:
12717618
39.

Paclitaxel (Taxol) attenuates clinical disease in a spontaneously demyelinating transgenic mouse and induces remyelination.

Moscarello MA, Mak B, Nguyen TA, Wood DD, Mastronardi F, Ludwin SK.

Mult Scler. 2002 Apr;8(2):130-8.

PMID:
11990870
40.

Microarray analysis of gene expression in multiple sclerosis and EAE identifies 5-lipoxygenase as a component of inflammatory lesions.

Whitney LW, Ludwin SK, McFarland HF, Biddison WE.

J Neuroimmunol. 2001 Dec 3;121(1-2):40-8.

PMID:
11730938
41.

The neuropathology of multiple sclerosis.

Ludwin SK.

Neuroimaging Clin N Am. 2000 Nov;10(4):625-48 ,vii. Review.

PMID:
11359716
42.

Inhibition of experimental allergic encephalomyelitis in the Lewis rat by paclitaxel.

Cao L, Sun D, Cruz T, Moscarello MA, Ludwin SK, Whitaker JN.

J Neuroimmunol. 2000 Aug 1;108(1-2):103-11.

PMID:
10900343
43.

Understanding multiple sclerosis: lessons from pathology.

Ludwin SK.

Ann Neurol. 2000 Jun;47(6):691-3. No abstract available.

PMID:
10852534
44.

Myelin associated glycoprotein modulates glia-axon contact in vivo.

Li C, Trapp B, Ludwin S, Peterson A, Roder J.

J Neurosci Res. 1998 Jan 15;51(2):210-7.

PMID:
9469574
45.

An enhancing optic nerve lesion: malignant glioma of adulthood.

Brodovsky S, ten Hove MW, Pinkerton RM, Ludwin SK, Smith RM.

Can J Ophthalmol. 1997 Oct;32(6):409-13. No abstract available.

PMID:
9363346
46.

The pathobiology of the oligodendrocyte.

Ludwin SK.

J Neuropathol Exp Neurol. 1997 Feb;56(2):111-24. Review. No abstract available.

PMID:
9034364
47.

The reactions of the oligodendrocyte.

Ludwin SK.

Mult Scler. 1996 Dec;2(5):241-3. Review. No abstract available.

PMID:
9050363
48.

Severe fetal asphyxia associated with neuropathology.

Low JA, Ludwin SK, Fisher S.

Am J Obstet Gynecol. 1996 Nov;175(5):1383-5.

PMID:
8942523
49.

Acute fulminant symmetrical vasculitic polyneuropathy: need for early biopsy.

Zochodne DW, Semmler RT, Ludwin SK, Auer R.

Clin Neuropathol. 1996 Mar-Apr;15(2):113-5.

PMID:
8925595
50.

Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group.

Cairncross G, Macdonald D, Ludwin S, Lee D, Cascino T, Buckner J, Fulton D, Dropcho E, Stewart D, Schold C Jr, et al.

J Clin Oncol. 1994 Oct;12(10):2013-21.

PMID:
7931469

Supplemental Content

Loading ...
Support Center